223 related articles for article (PubMed ID: 29288944)
1. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
3. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F
Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257
[TBL] [Abstract][Full Text] [Related]
4. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
5. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis.
Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J
Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
8. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
10. New chalcone-type compounds and 2-pyrazoline derivatives: synthesis and caspase-dependent anticancer activity.
Chouiter MI; Boulebd H; Pereira DM; Valentão P; Andrade PB; Belfaitah A; Silva AM
Future Med Chem; 2020 Mar; 12(6):493-509. PubMed ID: 32100558
[No Abstract] [Full Text] [Related]
11. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies.
Abourehab MAS; Alqahtani AM; Almalki FA; Zaher DM; Abdalla AN; Gouda AM; Beshr EAM
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770990
[TBL] [Abstract][Full Text] [Related]
13. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.
Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z
Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717
[TBL] [Abstract][Full Text] [Related]
15. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel chalcone-dithiocarbamates as ROS-mediated apoptosis inducers by inhibiting catalase.
Fu DJ; Li JH; Yang JJ; Li P; Zhang YB; Liu S; Li ZR; Zhang SY
Bioorg Chem; 2019 May; 86():375-385. PubMed ID: 30763884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bio-evaluation of indole-chalcone based benzopyrans as promising antiligase and antiproliferative agents.
Gupta S; Maurya P; Upadhyay A; Kushwaha P; Krishna S; Siddiqi MI; Sashidhara KV; Banerjee D
Eur J Med Chem; 2018 Jan; 143():1981-1996. PubMed ID: 29146133
[TBL] [Abstract][Full Text] [Related]
19. Chalcone-benzoxaborole hybrids as novel anticancer agents.
Zhang J; Yang F; Qiao Z; Zhu M; Zhou H
Bioorg Med Chem Lett; 2016 Dec; 26(23):5797-5801. PubMed ID: 28327308
[TBL] [Abstract][Full Text] [Related]
20. Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity.
Pinto P; Machado CM; Moreira J; Almeida JDP; Silva PMA; Henriques AC; Soares JX; Salvador JAR; Afonso C; Pinto M; Bousbaa H; Cidade H
Eur J Med Chem; 2019 Dec; 184():111752. PubMed ID: 31610374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]